50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Paper: TRANSCEND FL: Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as Second just got measured.
3.2/10 means Paper: TRANSCEND FL: Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as Second is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About Paper: TRANSCEND FL: Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as Second
ASH Home Start/Search Browse by Day Browse by Program Browse by Author ASH Meeting Home ASH Home -Author name in bold denotes the presenting author -Asterisk * with author name denotes a Non-ASH member denotes an abstract that is clinically relevant.
Details
Industry: Healthcare
abstractfl.comAI Visibility Breakdown
1
Structured Data
5
Content Structure
4
Entity Clarity
5
E-E-A-T Signals
4
Technical AEO
7
AI Discoverability
0
Backlinks
0
Domain Trust
0
Entity Presence
0
News Mentions
0
Community
0
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Paper: TRANSCEND FL: Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as Second.
Source & Attribution
Scored by Engagemii on July 22, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/abstractfl
Cite this score: Engagemii (2026). "AEO Score for Paper: TRANSCEND FL: Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as Second." Retrieved from https://engagemii.com/aeo/brands/abstractfl
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform